Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma
Clinical trial NCT03477110 · COMPLETED
Trial details
- NCT number
- NCT03477110
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-04
- Primary completion
- 2021-04-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.